Name
Nordic Tersus Laboratory OÜ
Registry code
12561442
VAT number
EE101714716
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
30.10.2013 (11)
Financial year
01.01-31.12
Capital
2 500.00 €
Activity
72191 - Other research and experimental development on natural sciences and engineering
145 415 €
3 058 €
2%
1 408 €
(estimate is approximate)
36 514 €
4
Submitted
No tax arrears
8%
6%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Ruth Oltjer 22.10.1959 (65) | 100% - 2 500.00 EUR | - | Direct ownership | Founder |
| Sander Piiskop 29.05.1985 (39) | - | Board member | - | |
| Aktsiaselts CHEMI-PHARM 10140819 | - | - | - | Founder |
| 2019 26.05.2020 | 2020 15.06.2021 | 2021 31.05.2022 | 2022 30.06.2023 | 2023 23.05.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 105 081 € | 130 109 € | 158 916 € | 136 951 € | 145 415 € |
| Net profit (loss) for the period | 8 725 € | 18 507 € | 17 721 € | -32 662 € | 3 058 € |
| Profit Margin | 8% | 14% | 11% | -24% | 2% |
| Current Assets | 6 886 € | 33 027 € | 45 123 € | 11 707 € | 21 580 € |
| Fixed Assets | 32 635 € | 30 768 € | 40 189 € | 37 623 € | 33 350 € |
| Total Assets | 39 521 € | 63 795 € | 85 312 € | 49 330 € | 54 930 € |
| Current Liabilities | 9 633 € | 15 400 € | 19 196 € | 15 874 € | 18 416 € |
| Non Current Liabilities | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 29 888 € | 48 395 € | 66 116 € | 33 456 € | 36 514 € |
| Employees | 3 | 4 | 4 | 5 | 4 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 28 964.5 € | 12 245.75 € | 8 865.69 € | 2 |
| 2023 Q4 | 25 611 € | 8 909.85 € | 7 455.48 € | 2 |
| 2023 Q3 | 37 333.98 € | 15 657.15 € | 10 566.79 € | 2 |
| 2023 Q2 | 29 105.82 € | 12 254.68 € | 9 641.48 € | 3 |
| 2023 Q1 | 46 066.27 € | 10 329.85 € | 9 070.37 € | 3 |
| 2022 Q4 | 37 531.75 € | 17 381.67 € | 12 829.76 € | 3 |
| 2022 Q3 | 46 483.97 € | 19 786.59 € | 12 807.99 € | 4 |
| 2022 Q2 | 25 257.49 € | 13 034.41 € | 10 598 € | 4 |
| 2022 Q1 | 36 355 € | 9 336.07 € | 8 295.25 € | 4 |
| 2021 Q4 | 20 449 € | 8 707.24 € | 8 148.27 € | 3 |
| 2021 Q3 | 11 393 € | 8 939.52 € | 8 866.67 € | 3 |
| 2021 Q2 | 86 602.96 € | 23 375.03 € | 9 414.96 € | 3 |
| 2021 Q1 | 50 075.5 € | 12 366.3 € | 8 244.39 € | 4 |
| 2020 Q4 | 29 660 € | 9 359.45 € | 7 869.56 € | 5 |
| 2020 Q3 | 27 248 € | 10 050 € | 7 503.06 € | 5 |
| 2020 Q2 | 31 961.25 € | 8 460.81 € | 5 916.03 € | 5 |
| 2020 Q1 | 25 505.25 € | 9 399.89 € | 6 493.17 € | 4 |
